Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue
Autor: | Régis Costello, J Colle, Raphael Cauchois, Gilles Kaplanski, Pierre-André Jarrot, Anne-Laure Couderc, Julie Lachamp, Rodolphe Jean, Antoine Tichadou, Geoffroy Venton, Arthur Boyer, Robin Arcani, Laure Farnault, Marie Koubi |
---|---|
Přispěvatelé: | Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Anthropologie bio-culturelle, Droit, Ethique et Santé (ADES), Aix Marseille Université (AMU)-EFS ALPES MEDITERRANEE-Centre National de la Recherche Scientifique (CNRS), RANCHON, GUILLAUME |
Rok vydání: | 2021 |
Předmět: |
Adult
Male medicine.medical_specialty Lymphoma [SDV]Life Sciences [q-bio] Haematologic malignancies Comorbidity Internal medicine Diabetes mellitus Diabetes Mellitus medicine Humans Hospital Mortality Mortality Multiple myeloma Aged Aged 80 and over Leukemia Hematology SARS-CoV-2 business.industry Malnutrition Smoking COVID-19 Super-spreader General Medicine Middle Aged Viral Load medicine.disease [SDV] Life Sciences [q-bio] Treatment Outcome Carriage Cardiovascular Diseases Hematologic Neoplasms Original Article Female Multiple Myeloma business Viral load |
Zdroj: | Annals of Hematology Annals of Hematology, 2021, 100 (11), pp.2799-2803. ⟨10.1007/s00277-021-04656-z⟩ |
ISSN: | 1432-0584 0939-5555 |
DOI: | 10.1007/s00277-021-04656-z |
Popis: | Specificities of COVID-19 disease course in patients with haematologic malignancies are still poorly studied. So, we aimed to compare patients with haematologic malignancies to patients without malignancies, matched by sex and age and hospitalised for COVID-19 at the same time and in the same centre. Among 25 patients with haematologic malignancies, we found that mortality (40% versus 4%, p |
Databáze: | OpenAIRE |
Externí odkaz: |